Association of Dietary and Supplemental Iron and Colorectal Cancer in a Population-Based Study

Publication/Presentation Date

11-1-2013

Abstract

We evaluated the role of dietary iron, heme iron, and supplemental iron on colorectal cancer (CRC) risk in a population-based case-control study in Pennsylvania, including 1005 incident cases and 1062 controls. Diet was assessed through a modified food frequency questionnaire that included supplement use and a meat-specific module. Cases reported intakes for the year before diagnosis, whereas controls reported intakes for the year before interview. Heme iron intake was calculated using a new heme database developed by the US National Cancer Institute. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using unconditional logistic regression. After multivariate adjustment, there were no significant associations between heme iron or total iron intake and CRC incidence. Dietary iron intake was inversely associated with CRC among women (OR Q5 vs. Q1=0.45; 95% CI=0.22-0.92), but not among men. Supplemental iron intake of more than 18 mg/day versus none was positively associated with CRC incidence (OR=2.31; 95% CI=1.48-3.59; P-trend

Volume

22

Issue

6

First Page

506

Last Page

511

ISSN

1473-5709

Disciplines

Medical Sciences | Medical Specialties | Medicine and Health Sciences | Oncology

PubMedID

23492957

Department(s)

Department of Medicine

Document Type

Article

Link to Full Text

Share

COinS